19 reports

About SENS-## Phase ## trial UCLH researchers are testing a new drug for sudden-onset sensorineural hearing loss (SSNHL), an emergency condition where there is a rapid loss in inner ear hearing - usually in one ear.

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Sensorion S.A.

Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear.

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Knopp Neurosciences, Inc.

These highly ototoxic medications can result in permanent, and often progressive inner ear disease.

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Knopp Neurosciences, Inc.
  • AZASETRON - DRUG PROFILE

The company provides treatment for Alzheimers disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications.

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Sensorion S.A.
  • EBSELEN - DRUG PROFILE

Patients will receive an administration of OTO-## in one ear prior to each of the first three cisplatin treatment cycles, with the contralateral ear as an untreated control.

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • United States
  • Product Initiative
  • Otonomy, Inc.

Patients will receive an administration of OTO-## in one ear prior to each of the first three cisplatin treatment cycles, with the contralateral ear as an untreated control.

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • United States
  • Product Initiative
  • Otonomy, Inc.

JUN ##, 2017: SENSORION TAKES A KEY STEP TOWARDS PHASE ## WITH SENS-## THANKS TO THE POSITIVE RESULTS OBTAINED IN THE PHASE ## CLINICAL TRIAL Sensorion, a biotech company specializing in the treatment of inner ear diseases, announces the positive results of the phase

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Sensorion S.A.
  • Clinical Trial profile. 74 Trial Title

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Clinical Trial
  • Ear Disease
  • Therapy
  • World
  • Product Initiative

JUN ##, 2017: SENSORION TAKES A KEY STEP TOWARDS PHASE ## WITH SENS-## THANKS TO THE POSITIVE RESULTS OBTAINED IN THE PHASE ## CLINICAL TRIAL Sensorion, a biotech company specializing in the treatment of inner ear diseases, announces the positive results of the phase

  • Ear Disease
  • Molecular Diagnostics
  • Therapy
  • Product Initiative
  • Sensorion S.A.

In this hepatic impairment study, ## patients with chronic liver disease, eight with mild disease, eight with moderate disease and eight with severe disease, were given a five-day course of solithromycin dosed as ## mg on day ## followed by ## mg once-da

  • Ear Disease
  • Therapy
  • United States
  • Product Initiative
  • Cempra, Inc.

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Auris Medical Holding AG

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Clinical Trial
  • Drug Development
  • Ear Disease
  • Therapy
  • Product Initiative
  • Target

Currently, there are no FDA approved drug treatments for MD, or any other inner ear disease.

  • Clinical Trial
  • Ear Disease
  • World
  • Product Initiative
  • Otonomy, Inc.
  • Clinical Trial profile. 35 Trial Title

Sensorion, a biotech company specializing in the treatment of inner ear diseases, announces the positive results of the phase ## clinical trial of SENS-## treatment of inner ear lesions.

  • Clinical Trial
  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 31 Trial Title
  • Clinical Trial Profile Snapshots

PROPORTION OF ACUTE SENSORINEURAL HEARING LOSS TO EAR NOSE THROAT DISORDERS CLINICAL TRIALS, E## COUNTRIES (%), PROPORTION OF ACUTE SENSORINEURAL HEARING LOSS TO EAR NOSE THROAT DISORDERS CLINICAL TRIALS, E## COUNTRIES (%), In total there were four clinical trials conducted on Acute

  • Ear Disease
  • Hospital
  • Therapy
  • World
  • Product Initiative

It was also under development for the treatment of myocardial infarction, organ transplantation, Meniere disease and Parkinson' s disease (cell transplantation).

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Auris Medical Holding AG

THE INVENTION RELATES TO METHODS AND KITS USEFUL FOR PROVIDING NEUROPROTECTION TO NEURONS IN THE INNER EAR AND TO METHODS OF TREATING INNER EAR DISEASES AND DISORDERS, INCLUDING TINNITUS AND MENIERE' S DISEASE.

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Quark

(Sensorion) is a biopharmaceutical company that develops treatment for the inner ear diseases.

  • Ear Disease
  • Medical Biotechnology
  • Molecular Diagnostics
  • Therapy
  • Product Initiative
  • Clinical Trial profile. 20 Trial Title
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • Auris Medical Holding AG